Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAT2306 vs Cosentyx in Moderate to Severe Plaque Psoriasis
NCT05377944Phase 3Completed
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Oct 2022
- Primary completion
- May 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of BAT2306 in plaque psoriasis, sponsored by Bio-Thera Solutions, Ltd.. Started Oct 2022; status: completed.
02
Drugs
BAT2306
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT05377944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05377944.